The emergence of medical innovations, new technologies and cutting-edge procedures spurred most of the annual changes presented in the release of the Current Procedural Terminology (CPT®) 2025, the nation’s uniform data-sharing code set for medical procedures and services published by the AMA.
Read More
The AMA announced an editorial update to Current Procedural Terminology, the leading medical terminology code set for describing health care procedures and services, that includes a newly assigned provisional CPT code for vaccines to protect patients against the H5N8 strain of avian influenza (bird flu).
The AMA announced an editorial update to Current Procedural Terminology (CPT)®, the nation’s leading medical terminology code set for describing health care procedures and services, that includes eight new codes for the bivalent COVID-19 vaccine booster doses from Moderna and Pfizer-BioNTech.
The American Medical Association announced an editorial update to Current Procedural Terminology (CPT®), the nation’s leading medical terminology code set for describing health care procedures and services, that includes new product and administration codes assigned to the Moderna COVID-19 vaccine for children 6 months through 5 years old.
The AMA announced an editorial update to Current Procedural Terminology, the nation’s leading medical terminology code set for describing health care procedures and services, that includes newly assigned provisional CPT codes for COVID-19 booster candidates from Pfizer and Sanofi-GlaxoSmithKline.
The AMA announced an editorial update to Current Procedural Terminology, the nation’s leading medical terminology code set for describing health care procedures and services, that includes new product and administration codes assigned to the Pfizer-BioNTech COVID-19 vaccine for children 6 months to under 5 years of age.
The American Medical Association announced an editorial update to the Current Procedural Terminology code set that includes a new vaccine administration code for a third dose of the pediatric COVID-19 vaccine developed by Pfizer.
The American Medical Association announced that the Current Procedural Terminology code set has been updated by the CPT Editorial Panel to include a new code for booster doses of COVID-19 vaccine created by Janssen Pharmaceutical Companies of Johnson & Johnson.
The AMA announced that the CPT® code set has been updated by the CPT Editorial Panel. The provisional CPT codes will be effective for use on the condition that Pfizer’s two-dose regimen for the prevention of COVID-19 in children ages 5 to 11 receives approval or emergency use authorization from the FDA.